Aimfinity Investment I Corp. Shareholders Extend Deadline for Docter Merger
Aimfinity Investment I Corp. shareholders have approved an extension of the deadline for its merger with Docter Inc. until October 28, 2025, with a possible further extension of up to nine months. Following this decision, 572,989 Class A ordinary shares were tendered for redemption, while 503,472 shares remain subject to redemption upon the merger's closing.